Exchange Announcement • 23 Dec 2024 20:35
Exchange Announcement • 07 Nov 2024 20:56
Exchange Announcement • 07 Nov 2024 20:45
Exchange Announcement • 15 Oct 2024 20:05
Exchange Announcement • 15 Oct 2024 20:00
ENTITY
Cingulate (CING US)
Cingulate (CING US)
2
Analysis
Health Care • United States
Cingulate Inc. operates as a clinical stage biopharmaceutical company. The Company develops pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.
more
x